Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis.
Mult Scler
; 24(6): 813-815, 2018 05.
Article
in En
| MEDLINE
| ID: mdl-29359617
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Multiple Sclerosis, Relapsing-Remitting
/
Albuminuria
/
Alemtuzumab
/
Immunologic Factors
/
Anemia, Hemolytic, Autoimmune
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
Mult Scler
Journal subject:
NEUROLOGIA
Year:
2018
Type:
Article
Affiliation country:
Italy